HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Inhibitors of proteolytic enzymes in the blood serum of patients with diphyllobothriasis].

Abstract
The proteinase inhibitors alpha 1-protease inhibitor (alpha 1-antitrypsin) and alpha 2-macroglobulin have been determined in 24 patients with diphyllobothriasis (D. latum and D. dendriticum), with their activity expressed in conventional units per ml serum inhibiting or binding the activity of 1 unit of trypsin, respectively. The specific activity of alpha 1-protease inhibitor and alpha 2-macroglobulin proved to be twice (46.2%) and thrice (32.7%) lower, respectively, despite a significant decrease in the total protein serum level. The ratio between these 2 parameters was 9.86 +/- 1.4, it being equal to 5.3 +/- 0.12 in the control. The authors believe that the reduced activity of alpha 1-protease inhibitor may be a protective response of the host to the invasion. Reduced activity is suggested to promote to chronic intestinal inflammation. Decreased activity of alpha 2-macroglobulin is accounted for by damages in its synthesis by monocyte-macrophage elements and probably by enhanced binding with proteinases of the parasite.
AuthorsL A Gosteva
JournalMeditsinskaia parazitologiia i parazitarnye bolezni (Med Parazitol (Mosk)) 1990 Jul-Aug Issue 4 Pg. 29-31 ISSN: 0025-8326 [Print] Russia (Federation)
Vernacular TitleIngibitory proteoliticheskikh fermentov syvorotki krovi bol'nykh difillobotriozom.
PMID1700263 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Blood Proteins
  • Protease Inhibitors
  • alpha 1-Antitrypsin
  • alpha-Macroglobulins
Topics
  • Blood Proteins (analysis)
  • Clinical Enzyme Tests
  • Diphyllobothriasis (diagnosis)
  • Humans
  • Protease Inhibitors (blood)
  • alpha 1-Antitrypsin (analysis)
  • alpha-Macroglobulins (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: